QIAGEN’s new QIAstat-Dx gastrointestinal panel demonstrates excellent performance in multicentre clinical study in Europe
The study also cited the ability of the QIAstat-Dx panel to provide cycle threshold (CT) values and amplification…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
16 Aug 19
The study also cited the ability of the QIAstat-Dx panel to provide cycle threshold (CT) values and amplification…
16 Aug 19
Q-NRG+ is a flexible, portable and easy to use metabolic monitor that requires minimal warm-up and calibration time,…
09 Aug 19
The collaboration between Myriad and AstraZeneca started in 2007 and has resulted in multiple regulatory approvals for BRACAnalysis…
08 Aug 19
Tangen completed the first phase in February 2019 and delivered a functional TangenDx Instrument with a sensitive Anthrax…
08 Aug 19
DiscGenics is engaged in developing regenerative cell-based therapies to relieve pain and reinstate function in patients with degenerative…
07 Aug 19
The new systems join the existing dual-channel Thermo Scientific Prelude MD HPLC and four-channel Thermo Scientific Prelude LX-4…
06 Aug 19
Lucira Health will use the funding to support early commercialization and regulatory clearances of its rapid and disposable…
06 Aug 19
Lucira Health is developing DNA- and RNA-based diagnostic tools for infectious diseases such as respiratory illnesses, sexually transmitted…
06 Aug 19
The US FDA has approved non-invasive, continuous SpHb for patients weighing 3kg, and is not currently indicated for…
05 Aug 19
The new Accelerate PhenoTest BC kit includes AST results for ceftazidime-avibactam and ceftolozane-tazobactam for Enterobacteriaceae and P. aeruginosa…